SOPH
SOPHiA GENETICS SA
7.40$
+1.5%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 74.4% | 71.8% | 69.4% | 69.4% | 66.0% | 64.0% | 61.4% | 65.9% | 63.3% | 60.8% | 61.0% | 69.2% | |
| 64.5% | 59.8% | 57.5% | 58.2% | 53.9% | 51.7% | 46.7% | 53.4% | 49.9% | 43.1% | 41.7% | 54.3% | |
| 64.5% | 59.8% | 57.5% | 58.2% | 53.9% | 51.7% | 46.7% | 53.4% | 49.9% | 43.1% | 41.7% | 54.3% | |
| 4.8% | 7.4% | 6.0% | 5.5% | 5.5% | 5.6% | 7.3% | 5.4% | 5.2% | 10.1% | 9.1% | 7.1% | |
| 2.5% | 3.1% | 3.3% | 3.6% | 3.6% | 3.8% | 3.4% | 3.5% | 4.1% | 3.9% | 4.5% | 3.6% | |
| 10.8% | – | – | – | – | – | – | – | – | – | – | – | |
| – | 4.4% | – | – | – | 5.4% | 20.4% | 19.0% | – | 5.9% | 22.8% | – | |
| 11.4% | 8.8% | 14.6% | 15.1% | 17.1% | 13.3% | 20.4% | 19.0% | 21.2% | 16.2% | – | 18.2% | |
| 23.0% | 26.5% | 26.6% | 32.9% | 36.1% | 37.9% | 41.6% | 56.8% | 62.9% | 71.1% | 70.9% | 58.1% | |
| 14.0% | 17.3% | 16.7% | 15.8% | 17.4% | 17.3% | 19.7% | 19.4% | 22.6% | 31.0% | 29.7% | 25.8% | |
| 1.4% | 1.4% | 1.5% | 1.4% | 1.4% | 1.4% | 1.6% | 1.4% | 1.6% | 1.7% | 1.7% | 1.4% | |
| 2.9% | 1.1% | 3.5% | 2.9% | 3.3% | 1.2% | 3.1% | 4.4% | 3.7% | 3.3% | 8.1% | 6.0% | |
| – | – | – | 7.4% | 7.4% | 8.5% | 9.1% | 26.7% | 29.1% | 29.3% | 30.5% | 24.2% | |
| 77.0% | 73.5% | 73.4% | 67.1% | 63.9% | 62.1% | 58.4% | 43.2% | 37.1% | 28.9% | 29.1% | 41.9% | |
| -171.8% | -183.3% | -217.2% | -224.6% | -239.4% | -283.5% | -311.9% | -270.3% | -305.9% | -318.5% | -343.1% | -282.8% | |
| 31.6% | 31.5% | 36.2% | 36.4% | 37.4% | 42.4% | 45.6% | 37.9% | 41.5% | 41.9% | 45.3% | 37.2% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.